Results 211 to 220 of about 51,558 (279)

DNAM-1 mediates NK-cell activation and host-pathogen interaction via direct binding to fungal cell wall proteases. [PDF]

Commun Biol
Natasha F, Heilig L, Helmerich DA, Luther C, Springer J, Kar B, Drobny M, Kasper L, Schuh C, Dittrich M, Hube B, Dandekar T, Sauer M, Löffler J, Terpitz U.   +14 more
europepmc   +1 more source

Antibody-Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy. [PDF]

J Extracell Vesicles
Parlekar B, Livingstone DW, Sutherland AR, Medina AX, Bernhard W, DeCoteau J, Hernández T, Geyer CR.   +7 more
europepmc   +1 more source

Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells. [PDF]

PLoS One
Calescibetta A, Dalton R, Fortenbery N, Ward G, Christiansen S, Chen X, Cheng P, Razabdouski T, Glode AJ, Tu N, Trinh TL, Liu J, Wright KL, Wei S, Eksioglu EA.   +14 more
europepmc   +1 more source

Flagellin co-expression potentiates mRNA vaccine-induced cytotoxic T lymphocyte responses but not anti-tumor immunity. [PDF]

Sci Rep
Li Y, Kang X, Song Y, Akter L, VanLuinen E, Nakkala JR, Chen X.   +6 more
europepmc   +1 more source

HIV controllers, lessons learnt from the lymphoid tissues. [PDF]

Curr Opin HIV AIDS
Mastrangelo A, Banga R, Perreau M.
europepmc   +1 more source

Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progression. [PDF]

Front Immunol
Abrate C, Brunotto V, Bossio SN, Boccardo S, Tosello Boari J, Caudana P, Hernandez L, Gimenez C, Theumer MG, Sedlik C, Amezcua-Vesely MC, Robson SC, Gruppi A, Piaggio E, Acosta Rodríguez EV, Montes CL.   +15 more
europepmc   +1 more source

Dual Regulation of Post-Translational Modification of Proteins: Bottlenecks and Breakthroughs in NK Cell Therapy for Glioblastoma. [PDF]

Int J Gen Med
Liu Y, Qiu Q, Deng H, Song P, Bu J, Zhang M.   +5 more
europepmc   +1 more source

Oral manifestations of anaplastic large cell lymphoma: clinicopathological features and main immunophenotypic findings of 3 cases. [PDF]

J Hematop
Rodrigues-Fernandes CI, de Siqueira IA, de Cáceres CVBL, Legarrea JMA, Neto VT, Lopes GM, da Cruz MC, Pontes HAR, Delgado-Azañero W, de Mendonça GRA, Vargas PA, Coracin FL, Fonseca FP.   +12 more
europepmc   +1 more source

Molecular mechanisms underlying T cell subset imbalance and precision therapeutic targets in primary biliary cholangitis. [PDF]

Front Pharmacol
Zhu B, Zhang C, Ma J, Luo Z, Huang S, Yang X, Wang L, Zhang W.   +7 more
europepmc   +1 more source